drugset / Trial / NCT04666714
Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Praga formulation in the treatment of neuropathic pain.
Timeline
- Start
- 2023-05-15
- Primary completion
- 2025-09-30
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Praga formulation | Unknown | — | Oral |
| Comparator | Pregabalin | Small molecule | 75 mg | Oral |
| Comparator | Pregabalin | Small molecule | 150 mg | Oral |